封面
市場調查報告書
商品編碼
1630851

全球脂質市場:按產品、類型、來源、應用、國家、公司分析(2025-2033 年)

Lipid Market Global Report by Product, Types, Source, Application, Countries and Company Analysis 2025-2033

出版日期: | 出版商: Renub Research | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

世界脂質市場規模

全球脂質市場規模預計將從 2024 年的 146.2 億美元增至 2033 年的 263.8 億美元,2025 年至 2033 年的複合年增長率為 6.78%。推動市場發展的是,人們日常飲食中需要攝取足夠的營養,對保健食品和補充品的需求也不斷增長。

推動脂質市場成長的因素

增加治療心血管疾病的選擇

在心血管護理中,脂質對於控制膽固醇和改善患者預後至關重要。此外,由於人們越來越關注脂質藥物和降低心血管風險的治療方案,醫療保健系統對更多脂質檢測、管理和治療方案的需求也隨之增加。例如,西南健康創新公司將於 2024 年 5 月推出一個新工具箱,以改善心血管疾病患者的脂質護理。透過有針對性的教育和服務重新設計,由協作脂質基金資助的薩默塞特脂質計畫改善了脂質管理,減少了等待時間並擴大了診所。

脂質檢測標準化的發展

隨著脂質測試變得更加標準化,膽固醇和脂質水平的測量將變得更加準確。隨著醫療保健走向精準醫療,對一致、可靠的脂質測試的需求日益增加,以便醫療保健專業人員能夠更好地評估風險並定制患者治療方案,從而推動市場擴張。例如,為了標準化心血管護理的膽固醇測試,診斷和實驗室醫學協會 (ADLM) 於 2024 年 9 月發佈了新的指南。透過降低空腹要求和改善膽固醇、非 HDL-C 和 LDL-C 的測量,該建議旨在提高脂質檢測的準確性並改善患者護理和檢測機會。

核酸輸送需求不斷增加

治療性核酸的傳遞很大程度上依賴脂質,因為它們可以提高藥物的穩定性和生物利用度。同時,該市場也受益於脂質輸送系統的進步,該系統需要可靠地將遺傳訊息傳遞到目標細胞。例如,2024年2月,贏創和美因茨大學決定將隨機聚乙二醇(rPEG)商業化,用於核酸的轉移。這些專用脂質是贏創藥物傳遞產品組合的一部分,旨在改善基因療法和 mRNA 疫苗等應用中的免疫原性。

脂質市場的課題

監理合規

法規遵循是脂質市場的一個主要關注點。這是因為製造商必須遵守不同地區關於產品標籤、營養聲明和安全法規的嚴格指導方針。各國法規的差異增加了複雜性,特別是在行銷健康相關產品和功能性脂質時。此外,為了遵守道德和環境標準,他們必須投資監控系統,以確保魚油和棕櫚油等永續來源成分的可追溯性。不遵守規定可能會導致法律後果並損害您的品牌聲譽。

永續性

在脂質業務中,永續性是一個關鍵問題,特別是在採購魚油和棕櫚油等原料時。過度生產和不可持續的捕撈方式可能會造成森林砍伐、生物多樣性喪失和海洋環境枯竭。消費者和監管機構對道德和生態採購的要求日益提高,迫使企業採用永續的做法。這包括採用替代的、可再生的脂質來源和認證,例如 RSPO(可持續棕櫚油圓桌會議)。平衡永續性、市場需求和獲利能力需要付出巨大的努力、創造力和供應鏈透明度。

本報告研究了全球脂質市場,並提供了有關市場動態、區域和細分分析以及關鍵參與者分析的資訊。

目錄

第 1 章簡介

第 2 章 研究方法

第 3 章執行摘要

第 4 章 市場動態

  • 成長動力
  • 課題

第 5 章世界脂質市場

第6章 市佔率

  • 按產品
  • 依類型
  • 依來源
  • 依用途
  • 依國家/地區

第 7 章產品

  • 三酸甘油酯
  • 磷脂
  • 鞘脂
  • 離子化脂質
  • 其他

第 8 章 類型

  • 歐米伽 3、歐米伽 6
  • 磷脂
  • 中鏈三酸甘油酯
  • 固醇

第 9 章 起源

  • 動物
  • 植物

第 10 章用途

  • 食品和飲料
  • 藥品
  • 營養和補充劑
  • 其他

第 11 章 國家

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 比利時
    • 荷蘭 火雞
    亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 泰國
    • 馬來西亞
    • 印尼
    • 澳大利亞
    • 紐西蘭
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 12 章 波特五力分析

第 13 章 SWOT 分析

第14章 主要公司分析

  • NOF Corporation
  • Stepan Company
  • Archer Daniels Midland
  • Cargill
  • Kerry Group
  • BASF AG
  • Merck KGaA
  • Koninklijke DSM N.V.
簡介目錄

Global Lipid Market Size

Lipid Market is expected to reach US$ 26.38 billion in 2033 from US$ 14.62 billion in 2024, with a CAGR of 6.78% from 2025 to 2033. The market is being supported by the increased requirement to incorporate adequate nutrition into the daily diet as well as the growing demand for healthy foods and supplements.

Lipid Industry Overview

Carbon, hydrogen, and oxygen make up the majority of the varied class of organic molecules known as lipids. They dissolve in organic solvents like ether and alcohol but not in water. Fats, oils, waxes, and phospholipids are examples of lipids, which are essential components of biological systems. They protect important organs, act as a significant source of energy, and offer insulation. Additionally, lipids play a crucial role in the fluidity and functionality of cell membranes. They also play a role in the synthesis of hormones and aid in the absorption of fat-soluble vitamins (A, D, E, and K). Animal fats, oils, butter, and nuts are common dietary sources.

Numerous reasons are driving the notable expansion of the lipid market. The demand for functional lipids, such omega-3 fatty acids and plant-based oils, which are known for their cardiovascular and cognitive benefits, has increased as a result of growing consumer awareness of health and wellbeing. Clean-label products and plant-based diets are becoming more and more popular, which helps the market grow. The market is also expanding as a result of the rising demand for lipids in the food, cosmetics, and pharmaceutical sectors, as well as their application in functional foods, supplements, and skincare products. The availability and quality of products are further improved by technological developments in lipid extraction and processing.

Growth Drivers for the Lipid Market

Increasing the Number of Cardiovascular Disease Management Options

In cardiovascular therapy, lipids are essential for controlling cholesterol and enhancing patient outcomes. Furthermore, the need for better lipid testing, management, and treatment choices within healthcare systems is driven by the increased emphasis on lipid medicines and therapeutic solutions to lower cardiovascular risks. For example, Health Innovation South West introduced a new toolbox in May 2024 to improve lipid care for patients with cardiovascular disease. Through focused education and service redesign, the Somerset Lipids Project-funded by the Collaborative Lipids Fund-improved lipid management, shortened wait times, and expanded clinics.

Developments in the Standardization of Lipid Testing

Measurements of cholesterol and lipid levels are more accurate when lipid testing is standardized. As healthcare moves toward precision medicine, there is an increasing need for consistent, trustworthy lipid tests to enable healthcare practitioners better assess risks and customize patient treatments, which will boost market expansion. To standardize cholesterol testing for cardiovascular treatment, for example, the Association for Diagnostics & Laboratory Medicine (ADLM) published new guidelines in September 2024. By lowering fasting requirements and improving cholesterol, non-HDL-C, and LDL-C readings, this advice seeks to increase the accuracy of lipid tests and improve patient care and testing accessibility.

Growing Need for Delivery of Nucleic Acids

The delivery of nucleic acids for therapeutic purposes depends heavily on lipids because they improve the stability and bioavailability of medication formulations. The market, on the other hand, gains from the growing advancement of lipid-based delivery systems, which are necessary for the secure transfer of genetic information into target cells. In February 2024, for example, Evonik and the University of Mainz decided to commercialize randomized polyethylene glycols (rPEGs) for the transport of nucleic acids. These specialty lipids, which are a component of Evonik's growing drug delivery portfolio, are intended to enhance immunogenicity profiles for uses including gene treatments and mRNA vaccines.

Challenges in the Lipid Market

Regulatory Compliance

In the lipid market, regulatory compliance is a major concern because manufacturers have to follow stringent guidelines for product labeling, health claims, and safety laws in various geographical areas. Differences in national regulations increase complication, particularly when it comes to marketing health-related products or functional lipids. Additionally, it is necessary to invest in monitoring systems to guarantee the traceability of raw materials, such as fish oils or palm oil sourced sustainably, in order to comply with ethical and environmental criteria. Noncompliance may lead to legal repercussions and harm to the reputation of the brand.

Sustainability

In the lipid business, sustainability is a significant issue, especially when it comes to the supply of raw materials like fish and palm oils. Deforestation, biodiversity loss, and the depletion of marine environments can result from overproduction and unsustainable harvesting methods. Businesses are under pressure to implement sustainable practices as a result of growing consumer and regulatory demands for ethical and ecologically friendly sourcing. This include employing alternative, renewable lipid sources and certifications such as RSPO (Roundtable on Sustainable Palm Oil). Significant effort, creativity, and supply chain transparency are needed to strike a balance between sustainability, market demand, and profitability.

Triglycerides, a key component of dietary fats and oils, are driving growth in the global market.

Triglycerides are popular in the lipid market. The surge is because of a growing customer base searching for healthier meal options and purposeful components. They are essential in offering strength, taste, and texture to numerous food products, thus maintaining significance in the food section. Furthermore, the growing occurrence of chronic illnesses consisting of weight problems and cardiovascular issues has initiated a shift in the direction of healthier fats, driving demand for triglycerides sourced from plant-based oils and other alternatives.

Phospholipids play a crucial role in the lipids market.

Phospholipids are experiencing an increase in the lipid market. Essential cell membrane additives contribute to structural integrity and cell structure. Also, phospholipids are applied in numerous industries, including food, prescribed drugs, and cosmetics, to combine and stabilize. With growing customer consciousness of health and well-being, the demand for products enriched with phospholipids is rising, propelling their increase in the market.

Plant-based sources are gaining popularity in the global market, offering sustainable and healthier alternatives for consumers.

Plant-based sources are growing in the global lipid market due to increasing consumer demand for healthier and sustainable alternatives. These sources offer dietary benefits, including essential fatty acids and advanced flavor and texture. Consumers are increasingly privy to the health benefits of plant-based lipids. Moreover, the developing emphasis on sustainability drives the choice for plant-based alternatives, which regularly have lower environmental influences than traditional lipid assets.

Growing consumer preferences and industry trends will drive the lipids sector in food and beverage applications.

The food and beverages segment is set for extensive enlargement in the international lipids market. Lipids enhance flavor, texture, and mouthfeel in diverse food products, contributing to their desirability. As fitness-aware customers search for functional and nutritious ingredients, lipids derived from sources like plant-based oils align with those wishes. Moreover, the developing reputation of comfort ingredients and processed systems similarly propels the demand for lipids, as they are critical to the appliance of those products.

Lipid Market Overview by Regions

The demand for functional and health-focused lipids is highest in North America and Europe, and the lipid market is expanding globally. Growing health consciousness is driving the Asia-Pacific region's rapid expansion, and rising markets are also fueling market expansion.

United States Lipid Market

Growing health consciousness and the need for functional ingredients are driving the robust expansion of the US lipid market. Because of their advantages for the heart and brain, consumers are looking for healthier fats including plant-based oils and omega-3 fatty acids. Clean-label products and plant-based diets are becoming more and more popular, which has an impact on the market. Lipids' market is further expanded by their extensive application in food, medicine, and cosmetics. The future of the U.S. lipid market is being shaped by technological developments in lipid extraction and processing, as well as an emphasis on sustainability and ethical sourcing.

In March 2024, CordenPharma introduced Lipid NanoParticle (LNP) Starter Kits for mRNA-based therapeutics. These kits include essential lipids for mRNA delivery and optimize LNP formulation, thereby ensuring efficient transfection across various cell types and applications, from R&D to clinical phases.

Germany Lipid Market

The growing demand for plant-based oils and omega-3s, two types of healthy fats, is driving the growth of the lipid market in Germany. Cleaner, more sustainable solutions are becoming more popular as consumers become more aware of the health benefits. The market is supported by the increasing usage of lipids in cosmetics, medications, and food. Germany's robust regulatory environment and emphasis on developing innovative methods for lipid extraction and processing also support market expansion. The region's consumer choices are also influenced by the need for sustainable sources.

Furthermore, with 23.9% of global pharmaceutical sales in 2020, Europe became the second-largest seller of pharmaceutical products, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA). Market expansion is anticipated to benefit from the widespread use of lipids in vaccine manufacturing as well as the large-scale internal production that is carried out by numerous European companies.

Japan Lipid Market

Growing consumer awareness of health and wellbeing is fueling the growth of the lipid industry in Japan. Omega-3 fatty acids in particular, which are prized for their cardiovascular and cognitive advantages, are in high demand as functional lipids. As more people look for sustainable, healthier options, plant-based oils and fats are becoming increasingly popular. The food, pharmaceutical, and cosmetics sectors in Japan make extensive use of lipids, with a focus on premium, clean-label goods. The market is also being shaped by developments in lipid extraction and processing technologies as well as an emphasis on sustainability. The need for lipid-based products that promote health is further increased by Japan's aging population.

UAE Lipid Market

Growing health consciousness and the need for high-quality, useful fats are driving the UAE's lipid market's expansion. Because of their nutritional advantages, consumers are looking for healthier options including plant-based oils and omega-3 fatty acids. Growing disposable earnings and a trend toward healthier eating are driving the industry. The food, pharmaceutical, and cosmetics sectors all make extensive use of lipids. With an emphasis on cleaner, more ethical products, sustainability trends and innovations in lipid extraction and processing are also influencing the industry.

Product - Market breakup in 5 viewpoints:

1. Triglycerides

2. Phospholipids

3. Sphingolipids

4. Ionizable Lipids

5. Others

Types - Market breakup in 4 viewpoints:

1. Omega-3 and Omega-6

2. Phospholipids

3. Medium Chain Triglycerides

4. Sterols

Sources - Market breakup in 2 viewpoints:

1. Animal

2. Plant

Application - Market breakup in 4 viewpoints:

1. Food & Beverages

2. Pharmaceuticals

3. Nutrition & Supplements

4. Others

Countries - Market breakup in 5 viewpoints:

1. North America

  • 1.1 United States
  • 1.2 Canada

2. Europe

  • 2.1 France
  • 2.2 Germany
  • 2.3 Italy
  • 2.4 Spain
  • 2.5 United Kingdom
  • 2.6 Belgium
  • 2.7 Netherland
  • 2.8 Turkey

3. Asia Pacific

  • 3.1 China
  • 3.2 Japan
  • 3.3 India
  • 3.4 South Korea
  • 3.5 Thailand
  • 3.6 Malaysia
  • 3.7 Indonesia
  • 3.8 Australia
  • 3.9 New Zealand

4. Latin America

  • 4.1 Brazil
  • 4.2 Mexico
  • 4.3 Argentina

5. Middle East & Africa

  • 5.1 Saudi Arabia
  • 5.2 UAE
  • 5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Developments
  • Revenue Analysis

Company Analysis:

1. NOF Corporation

2. Stepan Company

3. Archer Daniels Midland

4. Cargill

5. Kerry Group

6. BASF AG

7. Merck KGaA

8. Koninklijke DSM N.V.

Key Questions Answered in Report:

1. How big is the lipid industry?

The global lipid market size was valued at US$ 14.62 billion in 2024 and is expected to reach US$ 26.38 billion in 2033.

2. What is the lipid growth rate?

The global lipid market is expected to expand at a compound annual growth rate (CAGR) of 6.78% from 2025 to 2033.

3. Who are the key players in lipid industry?

The global lipid market includes companies such as NOF Corporation, Stepan Company, Archer Daniels Midland, Cargill, Kerry Group, BASF AG, Merck KGaA, and Koninklijke DSM N.V.

4. What are the factors driving the lipid industry?

The lipid market is growing due to rising health awareness, demand for functional lipids like omega-3s, plant-based diets, and their increasing use in food, pharmaceuticals, cosmetics, and supplements.

5. Which Region held the largest market share in the lipid industry?

North America is expected to hold the largest market share in the industry.

6. What segments are covered in the lipid market report?

Products, types, sources, application and Countries segment are covered in this report.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Lipid Market

6. Market Share

  • 6.1 By Product
  • 6.2 By Type
  • 6.3 By Source
  • 6.4 By Application
  • 6.5 By Countries

7. Product

  • 7.1 Triglycerides
  • 7.2 Phospholipids
  • 7.3 Sphingolipids
  • 7.4 Ionizable Lipids
  • 7.5 Others

8. Type

  • 8.1 Omega-3 and Omega-6
  • 8.2 Phospholipids
  • 8.3 Medium Chain Triglycerides
  • 8.4 Sterols

9. Source

  • 9.1 Animal
  • 9.2 Plant

10. Application

  • 10.1 Food & Beverages
  • 10.2 Pharmaceuticals
  • 10.3 Nutrition & Supplements
  • 10.4 Others

11. Countries

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
  • 11.2 Europe
    • 11.2.1 France
    • 11.2.2 Germany
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Belgium
    • 11.2.7 Netherland
    • 11.2.8 Turkey
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Thailand
    • 11.3.6 Malaysia
    • 11.3.7 Indonesia
    • 11.3.8 Australia
    • 11.3.9 New Zealand
  • 11.4 Latin America
    • 11.4.1 Brazil
    • 11.4.2 Mexico
    • 11.4.3 Argentina
  • 11.5 Middle East & Africa
    • 11.5.1 Saudi Arabia
    • 11.5.2 UAE
    • 11.5.3 South Africa

12. Porter's Five Forces Analysis

  • 12.1 Bargaining Power of Buyers
  • 12.2 Bargaining Power of Suppliers
  • 12.3 Degree of Rivalry
  • 12.4 Threat of New Entrants
  • 12.5 Threat of Substitutes

13. SWOT Analysis

  • 13.1 Strength
  • 13.2 Weakness
  • 13.3 Opportunity
  • 13.4 Threat

14. Key Players Analysis

  • 14.1 NOF Corporation
    • 14.1.1 Overview
    • 14.1.2 Recent Development
    • 14.1.3 Revenue Analysis
  • 14.2 Stepan Company
    • 14.2.1 Overview
    • 14.2.2 Recent Development
    • 14.2.3 Revenue Analysis
  • 14.3 Archer Daniels Midland
    • 14.3.1 Overview
    • 14.3.2 Recent Development
    • 14.3.3 Revenue Analysis
  • 14.4 Cargill
    • 14.4.1 Overview
    • 14.4.2 Recent Development
    • 14.4.3 Revenue Analysis
  • 14.5 Kerry Group
    • 14.5.1 Overview
    • 14.5.2 Recent Development
    • 14.5.3 Revenue Analysis
  • 14.6 BASF AG
    • 14.6.1 Overview
    • 14.6.2 Recent Development
    • 14.6.3 Revenue Analysis
  • 14.7 Merck KGaA
    • 14.7.1 Overview
    • 14.7.2 Recent Development
    • 14.7.3 Revenue Analysis
  • 14.8 Koninklijke DSM N.V.
    • 14.8.1 Overview
    • 14.8.2 Recent Development
    • 14.8.3 Revenue Analysis